NM_174936.4(PCSK9):c.1825A>C (p.Lys609Gln) AND Hypercholesterolemia, autosomal dominant, 3

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: May 31, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004015894.2

Allele description [Variation Report for NM_174936.4(PCSK9):c.1825A>C (p.Lys609Gln)]

NM_174936.4(PCSK9):c.1825A>C (p.Lys609Gln)

Gene:

PCSK9:proprotein convertase subtilisin/kexin type 9 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

1p32.3

Genomic location:

Preferred name:

NM_174936.4(PCSK9):c.1825A>C (p.Lys609Gln)

HGVS:

NC_000001.11:g.55061518A>C
NG_009061.1:g.26972A>C
NM_001407240.1:c.1948A>C
NM_001407241.1:c.1867A>C
NM_001407242.1:c.1828A>C
NM_001407243.1:c.1768A>C
NM_001407244.1:c.1651A>C
NM_001407245.1:c.1633A>C
NM_001407246.1:c.1450A>C
NM_001407247.1:c.1324A>C
NM_174936.4:c.1825A>CMANE SELECT
NP_001394169.1:p.Lys650Gln
NP_001394170.1:p.Lys623Gln
NP_001394171.1:p.Lys610Gln
NP_001394172.1:p.Lys590Gln
NP_001394173.1:p.Lys551Gln
NP_001394174.1:p.Lys545Gln
NP_001394175.1:p.Lys484Gln
NP_001394176.1:p.Lys442Gln
NP_777596.2:p.Lys609Gln
NP_777596.2:p.Lys609Gln
LRG_275t1:c.1825A>C
LRG_275:g.26972A>C
LRG_275p1:p.Lys609Gln
NC_000001.10:g.55527191A>C
NM_174936.3:c.1825A>C
NR_110451.3:n.2106A>C
NR_176318.1:n.1909A>C
NR_176319.1:n.2384A>C
NR_176320.1:n.2348A>C
NR_176321.1:n.2063A>C
NR_176322.1:n.2018A>C
NR_176323.1:n.1937A>C
NR_176324.1:n.2325A>C

Protein change:

K442Q

Molecular consequence:

NM_001407240.1:c.1948A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407241.1:c.1867A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407242.1:c.1828A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407243.1:c.1768A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407244.1:c.1651A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407245.1:c.1633A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407246.1:c.1450A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407247.1:c.1324A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_174936.4:c.1825A>C - missense variant - [Sequence Ontology: SO:0001583]
NR_110451.3:n.2106A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_176318.1:n.1909A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_176319.1:n.2384A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_176320.1:n.2348A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_176321.1:n.2063A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_176322.1:n.2018A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_176323.1:n.1937A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_176324.1:n.2325A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Observations:

Condition(s)

Name:: Hypercholesterolemia, autosomal dominant, 3 (FHCL3)
Synonyms:: Familial hypercholesterolemia 3; Familial Hypercholesterolemia, Autosomal Dominant, 3
Identifiers:: MONDO: MONDO:0011369; MedGen: C1863551; OMIM: 603776

Recent activity

Clear Turn Off Turn On

BB549335 RIKEN full-length enriched, 2 days pregnant adult female oviduct Mus mu...
BB549335 RIKEN full-length enriched, 2 days pregnant adult female oviduct Mus musculus cDNA clone E230015D02 3', mRNA sequence
gi|9620763|gnl|dbEST|5625012|dbj|BB 5.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004826226	All of Us Research Program, National Institutes of Health	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain Significance (May 31, 2023)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004826226

All of Us Research Program, National Institutes of Health

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain Significance
(May 31, 2023)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	1	not provided	not provided	108544	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From All of Us Research Program, National Institutes of Health, SCV004826226.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	108544	not provided	not provided		1	not provided	not provided	not provided

Last Updated: May 7, 2024

ClinVar

Relating variation to medicine